What to Know About This Fund's $7 Million Bet on an AI-Focused IT Turnaround

Access Investment Management disclosed a new 497,670-share position in DXC Technology, estimated at $6.68 million and equal to 1.67% of its reported 13F AUM. DXC remains under pressure, with the stock down nearly 40% over the past year, fiscal 2026 revenue down 2% to $12.6 billion, and management guiding for as much as a 5% sales decline in fiscal 2027. Offset by $713 million of free cash flow, $250 million of buybacks, and an AI-driven transformation push, the filing is more notable as a value/positioning signal than a direct catalyst.

Analysis

This is less a signal on DXC fundamentals than on positioning in a hated, cash-generative turnaround. A new ~2% AUM starter in a small-cap IT services name can matter because it often marks the start of an active engagement or a staged build, but it also leaves room for disappointment if the next two quarters do not show operating stabilization. The market is implicitly pricing a prolonged shrinkage story; any evidence that revenue declines are bottoming should have outsized multiple impact because the equity is already trading like a melting-ice-cube rather than a normalized services business.

The second-order winner from a successful DXC stabilization would be capital return, not top-line growth. With low earnings quality but real cash generation, the key debate is whether free cash flow can continue to outrun revenue erosion; if yes, buybacks become the main mechanism for per-share value creation and can support the stock even without obvious growth. The risk is that management’s AI/automation repositioning is more narrative than monetization, which could cause the market to re-rate the stock back toward distressed multiple territory if guidance is cut again.

From a relative value lens, this looks like a timing trade rather than a secular long. The contrarian setup is that sentiment may be too anchored on declining revenue while ignoring the leverage of a modestly better retention trend on valuation, but that only works if the next guidance reset is avoided. The opportunity set is therefore asymmetric around the next earnings print: near-term downside if organic declines accelerate, medium-term upside if management proves the decline is slowing and cash remains intact.

Key Decisions for Investors

• Tactically long DXC into the next earnings release only if the stock remains below 0.25x sales and management has not preannounced downside; target a 15-25% move higher on any credible stabilization, but keep a tight 8-10% stop if guidance worsens.
• Pair trade: long DXC / short a higher-multiple IT services peer basket over 1-3 months to isolate turnaround optionality while hedging sector beta; thesis only works if DXC’s cash flow holds and the market starts paying for capital returns.
• Use call spreads rather than stock for DXC if taking a bullish view: buy 3-6 month upside calls financed with higher strikes to express a catalyst-driven rerating with defined downside, since the name can gap lower on guidance.
• Avoid chasing the stock purely on the 13F signal; instead wait for confirmation in the next quarterly commentary around organic revenue trends and free cash flow, because a single new holder does not offset operating deterioration.
• If DXC rallies on sentiment alone without a measurable improvement in bookings or retention, fade strength via short-dated puts or a covered call overlay; the market has a history of overpaying for turnaround narratives before the numbers improve.